State Reverses Managed Medicaid for Nursing Homes After $91M Cost Spike in First Year

Why It Matters

The reversal curtails a costly, ineffective managed‑care experiment, protecting nursing‑home cash flow and freeing resources for underserved long‑term‑care patients. It signals to other states that fee‑for‑service may remain the safer Medicaid baseline for institutional care.

Key Takeaways

• Indiana's PathWays cost $91M more annually than fee‑for‑service
• Managed care added $300M over budget with no quality gains
• Bill HEA 1277 reverts 117,000 nursing‑home residents to fee‑for‑service by July 2027
• Insurers owed >$100M in delayed or improper payments to providers
• Savings will target 12,000‑person long‑term‑care waitlist

Pulse Analysis

Indiana’s abrupt shift away from the PathWays managed‑care Medicaid model underscores the challenges states face when trying to modernize long‑term‑care financing. Launched in July 2024, PathWays moved roughly 117,000 nursing‑home residents to private insurers—Humana, Elevance Health, and UnitedHealthcare—promising cost efficiencies and higher quality. However, independent analysis by Clifton Larson Allen revealed a $91 million annual premium overrun, translating to a $300 million budget shortfall in the first year, with no evidence of improved outcomes. The financial strain was compounded by billing errors, claim denials, and more than $100 million in delayed or improper payments to providers, eroding confidence among small‑to‑mid‑size skilled nursing facilities.

The new legislation, HEA 1277, not only restores fee‑for‑service reimbursement for long‑stay residents but also imposes individual cost caps for waiver participants and earmarks projected savings to shrink a nearly 12,000‑person waitlist for alternative long‑term‑care services. By reverting to a familiar payment structure, Indiana aims to stabilize cash flow for nursing homes, reduce administrative burdens, and restore provider trust. The move also obligates the state to seek federal approval for a standalone assisted‑living waiver, a strategic step intended to broaden access while containing costs.

Indiana’s experience offers a cautionary tale for other jurisdictions contemplating managed‑care transitions in the Medicaid arena. While private‑insurer partnerships can theoretically drive innovation, the lack of robust oversight and clear quality metrics can quickly turn cost‑saving promises into fiscal liabilities. Policymakers nationwide will watch Indiana’s outcomes closely, weighing the trade‑offs between potential efficiencies and the risk of destabilizing a vulnerable sector that serves millions of older Americans. The state’s decisive rollback may prompt a reevaluation of managed‑care pilots elsewhere, reinforcing the notion that fee‑for‑service remains a reliable safety net for institutional long‑term‑care funding.